2007
DOI: 10.1002/ar.20549
|View full text |Cite
|
Sign up to set email alerts
|

Effects of keratinocyte growth factor on intra‐alveolar surfactant fixed in situ: Quantitative ultrastructural and immunoelectron microscopic analysis

Abstract: Quantitative (immuno) transmission electron microscopy using design-based stereology was performed on specimens collected by means of systematic uniform random sampling of rat lungs, which were fixed by vascular perfusion to stabilize intra-alveolar surfactant in situ. This procedure ensures that the data recorded are representative of the whole organ. Ultrathin sections of specimens embedded at low temperature in Lowicryl HM20 were labeled by indirect immuno-gold staining for surfactant protein A. We observed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 49 publications
(63 reference statements)
1
0
0
Order By: Relevance
“…When administered intratracheally, KGF acts as a potent mitogen of alveolar epithelial type II cells, and the production of surfactant protein A associated with the tubular myelin fraction of the intra-alveolar surfactant increased by 47% in comparison with buffer-treated control lungs. In contrast, intra-alveolar surfactant subtypes were not affected [20]. However, we found in our previous study that the analog can inhibit the proliferation of fibroblasts markedly in a dose-dependent manner (data not shown), consistent with results of Tang and Gilchrest [21].…”
Section: Discussionsupporting
confidence: 78%
“…When administered intratracheally, KGF acts as a potent mitogen of alveolar epithelial type II cells, and the production of surfactant protein A associated with the tubular myelin fraction of the intra-alveolar surfactant increased by 47% in comparison with buffer-treated control lungs. In contrast, intra-alveolar surfactant subtypes were not affected [20]. However, we found in our previous study that the analog can inhibit the proliferation of fibroblasts markedly in a dose-dependent manner (data not shown), consistent with results of Tang and Gilchrest [21].…”
Section: Discussionsupporting
confidence: 78%